SHC
Sotera Health Company
$15.97
+$0.30(+1.95%)
49
Overall
40
Value
54
Tech
55
Quality
Market Cap
$4.55B
Volume
1.63M
52W Range
$10.80 - $19.85
Target Price
$20.13
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $931.5M | $1.0B | $1.0B | $1.1B | $1.2B | ||
| Total Revenue | $931.5M | $1.0B | $1.0B | $1.1B | $1.2B | ||
| COST OF GOODS SOLD | |||||||
| Cost of Revenue | $55.6M | $446.7M | $472.1M | $498.1M | $518.1M | ||
| GROSS PROFIT | |||||||
| Gross Profit | $875.9M | $557.0M | $577.2M | $602.3M | $645.5M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $261.9M | $308.7M | $300.5M | $242.6M | $252.8M | ||
| Selling, General & Administrative | $198.2M | $245.7M | $236.7M | $242.6M | $252.8M | ||
| General & Administrative Expenses | $198.2M | $245.7M | $236.7M | $242.6M | $252.8M | ||
| Salaries & Wages | $412.8M | $21.2M | $32.2M | $36.8M | $30.9M | ||
| Depreciation & Amortization | $64.2M | $64.3M | $76.6M | $84.3M | -- | ||
| Depreciation & Amortization | $64.2M | $64.3M | -- | -- | -- | ||
| Amortization | $1.1B | $1.1B | $1.1B | $1.1B | -- | ||
| Other Operating Expenses | $-63.8M | $-2.6M | -- | -- | -- | ||
| OPERATING INCOME | |||||||
| Operating income | $256.7M | $248.3M | $276.7M | $359.7M | $392.8M | ||
| EBITDA | $335.3M | $-11.7M | $415.9M | $449.4M | $445.4M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $2.5M | $80.1M | $142.9M | $164.7M | $155.7M | ||
| Intinc | $-74.2M | $-80.1M | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-74.2M | $-80.1M | $-142.9M | $-164.7M | $-155.7M | ||
| Gain on Sale of Securities | $1.2M | $-3.0M | -- | -- | -- | ||
| Other Income/Expense | $5.5M | $-411.3M | $-7.4M | $-5.3M | $-8.5M | ||
| Other Special Charges | $-5.5M | $6.4M | $7.4M | $5.3M | $8.5M | ||
| SPECIAL ITEMS | |||||||
| Restructring And Mn A Income | $-102.2M | $-182.4M | -- | -- | -- | ||
| Special Income Charges | $102.2M | $182.4M | $215.0M | -- | -- | ||
| Other Impairment Of Capital Assets | -- | $9.6M | -- | -- | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $178.2M | $-163.0M | $248.9M | $278.6M | $303.2M | ||
| Pre-Tax Income | $175.7M | $-243.1M | $106.0M | $113.9M | $147.5M | ||
| INCOME TAX | |||||||
| Tax Provision | $58.6M | $-9.5M | $54.7M | $69.5M | $69.6M | ||
| NET INCOME | |||||||
| Net Income | $116.9M | $-233.6M | $51.4M | $44.4M | $77.9M | ||
| Net Income (Continuing Operations) | $116.9M | $-233.6M | $51.4M | $44.4M | $77.9M | ||
| Net Income (Discontinued Operations) | $116.9M | $-233.6M | $51.4M | $44.4M | $77.9M | ||
| Net Income (Common Stockholders) | $116.9M | $-233.6M | $51.4M | $44.4M | $77.9M | ||
| Normalized Income | -- | -- | -- | -- | $146.0M | ||
| TOTALS | |||||||
| Total Expenses | $317.5M | $755.3M | $772.6M | $740.8M | $770.8M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $279.2M | $280.1M | $281.0M | $282.8M | $284.0M | ||
| Average Shares Outstanding (Diluted) | $279.4M | $280.1M | $283.2M | $284.9M | $286.4M | ||
| Shares Outstanding | $282.9M | $282.4M | $282.8M | $283.5M | $284.4M | ||
| Basic EPS | $0.41 | $-0.83 | $0.18 | $0.16 | $0.27 | ||
| Basic EPS (Continuing Operations) | $0.41 | $-0.83 | $0.18 | $0.16 | $0.27 | ||
| Diluted EPS | $0.41 | $-0.83 | $0.18 | $0.16 | $0.27 | ||
| Diluted EPS (Continuing Operations) | $0.41 | $-0.83 | $0.18 | $0.16 | $0.27 | ||
| OTHER METRICS | |||||||
| Minority Interests | $-239.0K | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | $408.0M | -- | -- | -- | ||
| Other Gand A | $198.2M | $245.7M | $236.7M | $242.6M | $252.8M | ||
| Restruct | $-102.2M | $-182.4M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SHC | $15.97 | +1.9% | 1.63M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |